Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?
Dalekos
George N
GN
Bogdanos
Dimitrios P
DP
Neuberger
James
J
D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000453:epidemiology*; D015415:Biomarkers / Q000032:analysis; D002446:Celiac Disease / Q000453:epidemiology / Q000276:immunology*; D005260:Female; D019204:GTP-Binding Proteins / Q000276:immunology; D005983:Glutens / Q000276:immunology; D006801:Humans; D015994:Incidence; D017093:Liver Failure / Q000453:epidemiology / Q000276:immunology* / Q000601:surgery; D016031:Liver Transplantation / Q000379:methods; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D011503:Transglutaminases / Q000276:immunology
D001323:Autoantibodies; D015415:Biomarkers; D005983:Glutens; D011503:Transglutaminases; D019204:GTP-Binding Proteins